Personalized fluid levels cuts acute kidney injury

Personalized fluid levels cuts acute kidney injury

(HealthDay)—A new fluid protocol is safe and effective in preventing contrast-induced acute kidney injury in patients undergoing cardiac catheterization, according to a study published in the May 24 issue of The Lancet.

Somjot S. Brar, M.D., from Kaiser Permanente in Los Angeles, and colleagues conducted a phase 3 trial involving 396 adult undergoing (with an estimated of ≤60 mL/min/1.73 m² and one or more of several risk factors). Patients were randomized (1:1) to either left ventricular end-diastolic pressure-guided volume expansion (196 participants) or a control group where they received a standard fluid administration protocol (200 participants).

The researchers found that contrast-induced acute kidney injury occurred less frequently in patients in the left ventricular end-diastolic pressure-guided group (6.7 percent versus 16.3 percent in the control group; relative risk, 0.41; P = 0.005). Shortness of breath occurred in three patients in each group, requiring hydration treatment to be prematurely terminated.

"Left ventricular end-diastolic pressure-guided fluid administration seems to be safe and effective in preventing contrast-induced in patients undergoing cardiac catheterization," the authors write.


Explore further

Hydration based on ventricular pressure is effective in reducing kidney damage in patients undergoing cardiac catheteriz

More information: Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Journal information: The Lancet

Copyright © 2014 HealthDay. All rights reserved.

Citation: Personalized fluid levels cuts acute kidney injury (2014, May 28) retrieved 22 October 2019 from https://medicalxpress.com/news/2014-05-personalized-fluid-acute-kidney-injury.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more